The total return over the past 12 months is +23.24% vs. +16.94% for the S&P 500. So far it's up +38.39% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +23.24% | +19.11% | (18.36%) | N/A | N/A | N/A |
| Total Return CAGR | +23.24% | +19.11% | (18.36%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cardiol Therapeutics Inc. (CRDL)
| Year | Start price | End price | CRDL Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.95 | $1.32 | +38.39% | +14.51% | +23.88% |
| 2025 | $1.28 | $0.95 | (25.48%) | +17.72% | (43.20%) |
| 2024 | $0.84 | $1.28 | +51.80% | +24.89% | +26.91% |
| 2023 | $0.51 | $0.84 | +65.33% | +26.19% | +39.14% |
| 2022 | $1.85 | $0.51 | (72.43%) | (18.17%) | (54.26%) |
| 2021 | $2.18 | $1.85 | (15.14%) | +28.74% | (43.88%) |
| 2020 | $3.54 | $2.18 | (38.35%) | +18.37% | (56.72%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
